Modulating serine biosynthesis for the treatment of dilated cardiomyopathy
- PMID: 35804196
- DOI: 10.1038/s41569-022-00751-4
Modulating serine biosynthesis for the treatment of dilated cardiomyopathy
Comment on
-
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.Eur Heart J. 2022 Sep 21;43(36):3477-3489. doi: 10.1093/eurheartj/ehac305. Eur Heart J. 2022. PMID: 35728000 Free PMC article.
References
Original article
-
- Perea-Gil, I. et al. Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy. Eur. Heart J. https://doi.org/10.1093/eurheartj/ehac305 (2022) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources